STEPHANIE BOVEE: Open Payments
NPI 1346697240 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 27 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $194 · 2025 $673
Food & beverage: $591Education: $81
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $270 |
| Teva Pharmaceuticals USA, Inc. | 2 | $100 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Lundbeck LLC | 2 | $50 |
| Novo Nordisk Inc | 3 | $49 |
| ABBVIE INC. | 1 | $23 |
| PFIZER INC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: AIRSUPRA, Auvelity, REXULTI, BREZTRI, FARXIGA, QULIPTA, Ozempic, ELIQUIS.
Industry payments across MI — which companies pay providers there.
